Chronic granulomatous disease as a risk factor for autoimmune disease. - Wikidata - wikimedia - TriplyDB

Chronic granulomatous disease as a risk factor for autoimmune disease.

Chronic granulomatous disease as a risk factor for autoimmune disease.

http://www.wikidata.org/entity/Q37450327

about

High levels of Crohn's disease-associated anti-microbial antibodies are present and independent of colitis in chronic granulomatous disease Mechanism-Based Strategies for the Management of Autoimmunity and Immune Dysregulation in Primary Immunodeficiencies Residual NADPH oxidase and survival in chronic granulomatous disease Hyperoxygenation attenuated a murine model of atopic dermatitis through raising skin level of ROS Orofacial findings in chronic granulomatous disease: report of twelve patients and review of the literature.Role of Protein Kinase C and Nox2-Derived Reactive Oxygen Species Formation in the Activation and Maturation of Dendritic Cells by Phorbol Ester and Lipopolysaccharide.Recurrent erythematous plaques on sun-exposed sites in an African American boy with chronic granulomatous disease Experimental lupus is aggravated in mouse strains with impaired induction of neutrophil extracellular traps.Ncf1 (p47phox) is essential for direct regulatory T cell mediated suppression of CD4+ effector T cells.Diabetes, renal and cardiovascular disease in p47 phox-/- chronic granulomatous disease.Reactive oxygen species deficiency induces autoimmunity with type 1 interferon signature.Phagocyte NADPH oxidase restrains the inflammasome in ANCA-induced GN Spontaneous and aging-dependent development of arthritis in NADPH oxidase 2 deficiency through altered differentiation of CD11b+ and Th/Treg cells Chronic granulomatous disease: overview and hematopoietic stem cell transplantation Reactive oxygen species prevent imiquimod-induced psoriatic dermatitis through enhancing regulatory T cell function Attenuation of experimental colitis in glutathione peroxidase 1 and catalase double knockout mice through enhancing regulatory T cell function Systemic lupus erythematosus-associated neutrophil cytosolic factor 2 mutation affects the structure of NADPH oxidase complex Lupus-associated causal mutation in neutrophil cytosolic factor 2 (NCF2) brings unique insights to the structure and function of NADPH oxidase.CD4(+) T cell vaccination overcomes defective cross-presentation of fungal antigens in a mouse model of chronic granulomatous disease.Redox Regulation of Pro-IL-1β Processing May Contribute to the Increased Severity of Serum-Induced Arthritis in NOX2-Deficient Mice.Loss of NOX-Derived Superoxide Exacerbates Diabetogenic CD4 T-Cell Effector Responses in Type 1 Diabetes NADPH oxidase controls neutrophilic response to sterile inflammation in mice by regulating the IL-1α/G-CSF axis.An efferocytosis-induced, IL-4-dependent macrophage-iNKT cell circuit suppresses sterile inflammation and is defective in murine CGD Glutathione peroxidase 1 deficiency attenuates concanavalin A-induced hepatic injury by modulation of T-cell activation.Noncanonical autophagy inhibits the autoinflammatory, lupus-like response to dying cells.B-cell activating factor (BAFF) is elevated in chronic granulomatous disease.A role for NADPH oxidase in antigen presentation.Infections associated with chronic granulomatous disease: linking genetics to phenotypic expression.Tolerance and autoimmunity in primary immunodeficiency disease: a comprehensive review.Pulmonary manifestations of chronic granulomatous disease.Autoimmunity in immunodeficiency.Genetics and epigenetics of systemic lupus erythematosus.Clinical manifestations of disease in X-linked carriers of chronic granulomatous disease.Interplay of infections, autoimmunity, and immunosuppression in systemic lupus erythematosus.Phagocyte NADPH oxidase and specific immunity.Rheumatologic manifestations of primary immunodeficiency diseases.Reactive oxygen homeostasis - the balance for preventing autoimmunity.Monocyte/macrophage-specific NADPH oxidase contributes to antimicrobial host defense in X-CGD.Monogenic Lupus.New insights into the immunopathogenesis of systemic lupus erythematosus.

P2860

Q24633510-BA76CBDC-026B-4694-AF58-471AB8DB9801 Q28066193-9C815D66-EED0-4582-B78F-9ACD187FC4B2 Q28301969-8B5DE903-F626-4B05-9601-6596095F60C0 Q28543509-3782C37F-8B5B-42DD-B6D8-BDFD47CE5462 Q33531937-E2C97E8A-567E-4099-824D-84D2167307B6 Q33552201-CEC169A2-77AE-4E23-8D8B-46938BEE9018 Q33555723-9F7F7F93-6588-47B3-8942-FF35C7E64E4E Q33703190-C9CF8E78-4D53-4A09-97CC-8E8B6439FF4C Q33799283-C6A7BA51-051B-4F79-B39A-DD6FC4413AB8 Q33849142-836AF987-0C3C-469B-B7FB-AED6F4626368 Q34471099-6837F72F-20A4-45D0-A0CF-567517290468 Q35027263-053E581D-8162-46B7-8E14-F6A027709CB4 Q35035200-38451052-5EE6-4349-879C-E820E9079793 Q35098193-A13DF052-2235-4545-9A9E-54B3D2569E50 Q35114429-67F2125C-5EE0-438A-AE21-CC798E601550 Q35151625-EE98E725-C620-4AEE-843C-F5AA31D07E63 Q35608083-8A96DC80-E6E0-4B5B-890E-95EFE56CA28D Q35673745-4779D595-3D44-4C38-915A-02B5A9C5A516 Q35913715-83796103-6901-46A6-B902-FF746EBF9303 Q36218924-9691B966-6CBB-4FB1-A7F3-F3D3586E0877 Q36311560-8FE80D69-82FD-4A15-A7C6-0856109AE919 Q36382191-B7E14065-4E0A-43D6-A959-045E56F21145 Q36797270-34CDBBFA-4CCE-4717-B08D-14DF9654E693 Q36866499-36E557BC-1D82-4398-B97A-A4B5F5A4129B Q36880014-9DE1C350-4204-4C41-A7DF-913F2CC87A44 Q37174792-58F2A784-891A-46AD-ADA3-0D2CE1F12291 Q37190119-0ECA2660-E70E-4533-98F4-DCDAADE1D20E Q38048847-1DE3D0CC-B78E-4F74-B392-7A7D9FF9661D Q38072386-1840D7AF-7FC6-4D6E-8B63-B76E96B3701A Q38079835-D16713FB-2D42-479C-B60C-B3934AEE8480 Q38099528-8330A73E-B336-47E3-AB6D-1468061AC8A1 Q38128800-31DF6FB5-D1A4-4FB3-BC01-51AACCB8F97D Q38146948-BD9C0F76-087B-4106-9A68-99F79CE4C367 Q38182646-0487D346-F665-439C-99A1-E88CB1A7A7E8 Q38373915-6CBF732C-A308-4D11-BEE8-214A3053F270 Q38772416-B4254836-EB1C-4B1C-A870-068B2353E35A Q38851117-46C75FB6-DD00-4775-8B68-217CF218081A Q38911356-7CE7D113-4DF3-4A53-8399-4D45BF660BE9 Q38998368-6CEC5778-3DBB-445F-8850-F0ED6C9F96B9 Q39016144-48C8B221-4F1E-4DD7-9C41-DC4D5223D130

P2860

Chronic granulomatous disease as a risk factor for autoimmune disease.

http://www.wikidata.org/entity/Q37450327

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 26 September 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Chronic granulomatous disease as a risk factor for autoimmune disease.

@en

Chronic granulomatous disease as a risk factor for autoimmune disease.

@nl

type

label

Chronic granulomatous disease as a risk factor for autoimmune disease.

@en

Chronic granulomatous disease as a risk factor for autoimmune disease.

@nl

prefLabel

Chronic granulomatous disease as a risk factor for autoimmune disease.

@en

Chronic granulomatous disease as a risk factor for autoimmune disease.

@nl

P1433

Q37450327-E685D96A-2A60-4DE2-B778-F067D6C33567

P1476

Q37450327-DA673F8B-1019-42C9-94C8-EF794E9120BF

P2093

Q37450327-28D095CD-11CA-4B47-82CA-19106E51820A

Q37450327-3548E065-04CC-42E9-95C9-80B199EC9A43

Q37450327-5B2EA7DC-78FC-4A0C-9644-34E217A14E3E

Q37450327-6B802462-5330-480D-B079-01F3B94B1A38

Q37450327-8BBC22EF-586D-459F-8EF4-5321079E3CA6

Q37450327-8E5AE5B2-D101-4A60-8AB1-BA9A63EA94A1

Q37450327-8F56FA1A-450F-4426-B0F1-4D36EBA2AA93

Q37450327-D82CF756-E847-4404-971E-8E532658581D

Q37450327-FA91D49B-C859-4432-B55C-FD014A76DD0B

Q37450327-FC8A0DD7-1004-4F01-86E8-E5A4D63A368F

P2860

Q37450327-00022EDC-BC2F-4C5E-A24F-67F12B0DF1F6

Q37450327-0F01AC72-4339-417C-8EF4-62D21405954C

Q37450327-13789CE5-FE43-4E7D-BC25-36964AB615B9

Q37450327-19DA6D20-FFFD-4C16-9129-ED67D52FC146

Q37450327-1AF82613-7A55-4D9A-84AE-ABA8DB400E1B

Q37450327-1FE7814F-ADC5-4AB6-81F6-28C95AA9C52A

Q37450327-2019B534-0AFC-4864-9C16-B95696F72AEA

Q37450327-322A3CC8-DBC2-41AF-A489-58B884BE51EE

Q37450327-386EF4DC-342E-4E9D-B9FA-05BA819CD621

Q37450327-402D7F18-A69B-445E-BF63-451E140928A7

P304

Q37450327-DC30F8A2-F63F-4157-8F17-71BFB7AA99B4

P31

Q37450327-2CBBBD86-0CBB-40F6-9697-E7BF2CE002E2

P356

Q37450327-C180453C-601E-4508-9C8D-1E66E5800DA9

P407

Q37450327-FB66E4AF-086A-4CE2-B3C4-305806BD32A8

P433

Q37450327-E21637F9-2F93-4762-934D-FF92652FD0F7

P478

Q37450327-6427EF1B-FB7E-413D-B8CD-6EF6047A492B

P50

Q37450327-F113E03F-1D57-4013-B124-C6FFDF249A90

P577

Q37450327-98CA4177-5966-44A3-BF8C-BE027E05193B

P5875

Q37450327-EA65D5E0-2CC0-49A7-82DE-F08850E2F497

P698

Q37450327-337B8988-C5A9-4106-9A40-FF9834F6DF0C

P921

Q37450327-8AA7B6F7-34E4-43D5-841E-9DB9CA0CA24C

P932

Q37450327-D555F733-CC20-4537-A916-8DD91A35B383

P356

J.JACI.2008.07.050

P1433

The Journal of Allergy and Clinical Immunology

P1476

Chronic granulomatous disease as a risk factor for autoimmune disease.

@en

P2093

Dianne Hilligoss

http://www.w3.org/2001/XMLSchema#string

Edward W Cowen

http://www.w3.org/2001/XMLSchema#string

James E Balow

http://www.w3.org/2001/XMLSchema#string

John I Gallin

http://www.w3.org/2001/XMLSchema#string

Julia Friend

http://www.w3.org/2001/XMLSchema#string

Karyl S Barron

http://www.w3.org/2001/XMLSchema#string

Maria L Turner

http://www.w3.org/2001/XMLSchema#string

Martha Marquesen

http://www.w3.org/2001/XMLSchema#string

Nora Naumann

http://www.w3.org/2001/XMLSchema#string

Suk See De Ravin

http://www.w3.org/2001/XMLSchema#string

P2860

Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production

Defining criteria for autoimmune diseases (Witebsky's postulates revisited)

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

The p47phox mouse knock-out model of chronic granulomatous disease

T cells express a phagocyte-type NADPH oxidase that is activated after T cell receptor stimulation

Genetic, biochemical, and clinical features of chronic granulomatous disease.

Immune deficiency and autoimmunity.

A female case of chronic granulomatous disease (CGD) associated with chronic idiopathic thrombocytopenic purpura.

Venous thromboembolism: pathophysiology, clinical features, and prevention

Lupus erythematosus-like lesions in a carrier of X-linked chronic granulomatous disease.

P304

1097-1103

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JACI.2008.07.050

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

122

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-09-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23289528

http://www.w3.org/2001/XMLSchema#string

P698

18823651

http://www.w3.org/2001/XMLSchema#string

P921

P932

2786235

http://www.w3.org/2001/XMLSchema#string